Carregant...
Effect of statin treatment in obese selenium-supplemented mice lacking selenocysteine lyase
People with obesity are often dyslipidemic and prescribed statins to prevent cardiovascular events. A common side effect of statin use is myopathy. This could potentially be caused by the reduction of selenoproteins that curb oxidative stress, in turn, affecting creatine metabolism. We determined if...
Guardat en:
| Publicat a: | Mol Cell Endocrinol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8263501/ https://ncbi.nlm.nih.gov/pubmed/34052303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2021.111335 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|